Reuters

ResMed says its masks to remain on market despite FDA classification

Jan 16 (Reuters) - ResMed (RMD.N), opens new tab said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the ...
Morningstar

ResMed Earnings: Strong Mask Sales and Cost Control Offset U.S. Device Softness

We maintain our USD 258 fair value estimate for narrow-moat ResMed RMD, or AUD 40 per CDI at current exchange rates, following first-quarter fiscal 2024 results. Underlying EBIT of USD 319 million ...
Nasdaq

ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...
Healio

ResMed CPAP masks subject to Class I recall over magnetic interference issue

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
Morningstar

ResMed's Positive Mix Shift to Higher-Margin Masks Should Drive Gross Margin Expansion

ResMed focuses on developing medical devices to treat sleep apnoea and other respiratory problems, and on educating caregivers about therapy options. The firm's product portfolio consists of airflow ...